United States · FDA National Drug Code directory
BUPROPION HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-7786_7592d5b6-97f7-4c5b-ae4d-684725f1f139
- Product NDC
- 68788-7786
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- BUPROPION HYDROCHLORIDE
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201021
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPROPION HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-1) · 68788-7786-1
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-3) · 68788-7786-3
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-6) · 68788-7786-6
- 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-8) · 68788-7786-8
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-9) · 68788-7786-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →